O-013Impact of age and gender on safety and efficacy of first-line FOLFOXIRI/bevacizumab in mCRC: a pooled analysis of TRIBE and TRIBE2 studies. (2nd July 2019) - Zucchelli, G; Marmorino, F; Rossini, D; Aprile, G; Casagrande, M; Lonardi, S; Murgioni, S; Dell'Aquila, E; Tomasello, G; Moretto, R; Antoniotti, C; Borelli, B; et al.